Evidence map›Paper›PMID 31518058›Full record

Trial reportJournal of the International AIDS Society2019

Who is seeking antiretroviral treatment for HIV now? Characteristics of patients presenting in Kenya and South Africa in 2017-2018.

Alana T Brennan, Mhairi Maskew, Bruce A Larson, Isaac Tsikhutsu, Margaret Bii, Lungisile Vezi, Matthew P Fox, Willem Df Venter, Peter Ehrenkranz, Sydney Rosen

2 registry-linked trialsOpen access · goldAbstract readMulticenter StudyPragmatic Clinical TrialRandomized Controlled Trial
In one paragraph

Trial report in Journal of the International AIDS Society, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02891135 nacompletednot on this map

Randomized Evaluation of a Simplified Clinical Algorithm for Identifying Patients Eligible for Immediate Initiation of Antiretroviral Therapy for HIV

TypeinterventionalSponsorBoston UniversityRan2017 to 2020Enrolled1,077ConditionsHIVArmsSLATE
NCT03315013 nacompletednot on this map

Randomized Evaluation of a Revised, Simplified Clinical Algorithm for Identifying Patients Eligible for Immediate Initiation of Antiretroviral Therapy for HIV (SLATEII)

TypeinterventionalSponsorBoston UniversityRan2018 to 2020Enrolled600ConditionsHIV/AIDS, Antiretroviral TherapyArmsSLATE II
3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Performance Evaluation of BD FACSPrestoDiagnostics (Basel, Switzerland) · 2022
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Alana T BrennanDepartment of Global Health, Boston University School of Public Health, Boston, MA, USA.
Mhairi MaskewHealth Economics and Epidemiology Research Office, Department of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Bruce A LarsonDepartment of Global Health, Boston University School of Public Health, Boston, MA, USA.ORCID 0000-0002-9322-2387
Isaac TsikhutsuKenya Medical Research Institute/U.S. Army Medical Research Directorate-Africa, Nairobi, Kenya.
Margaret BiiKenya Medical Research Institute/U.S. Army Medical Research Directorate-Africa, Nairobi, Kenya.
Lungisile VeziHealth Economics and Epidemiology Research Office, Department of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Matthew P FoxDepartment of Global Health, Boston University School of Public Health, Boston, MA, USA.
Willem Df VenterWits Reproductive Health and HIV Institute, Department of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Peter EhrenkranzBill and Melinda Gates Foundation, Seattle, WA, USA.ORCID 0000-0003-2028-4779
Sydney RosenDepartment of Global Health, Boston University School of Public Health, Boston, MA, USA.
Boston University · USUniversity of the Witwatersrand · ZAUnited States Army Medical Research Directorate - Africa · KEGates Foundation · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionMany African countries have had at least two years' experience with universal treatment eligibility for HIV. The literature contains few descriptions, though, of populations starting treatment since adoption of universal eligibility. Using baseline data from a clinical trial of same-day ART initiation, we describe the populations presenting for HIV testing or care at study clinics in Kenya and South Africa in 2017-18, during the era of same-day initiation.

methodsThe Simplified Algorithm for Treatment Eligibility (SLATE) trials in Kenya (SLATE I) and South Africa (SLATE II) were multicenter, non-blinded, individually randomized, pragmatic trials evaluating simple, standardized algorithms to determine eligibility for same-day initiation of ART without relying on laboratory results, point of care tests or multiple clinic visits. In Kenya, enrolment occurred during July 2017 to April 2018. In South Africa, enrolment occurred during March to September 2018. We describe demographic, socioeconomic and clinical characteristics of patients randomized to the same-day initiation arm for both studies. RESULTS AND DISCUSSION: A total of 240 and 296 participants were enrolled in Kenya and South Africa. The majority were female (59% and 64% respectively), with a median age of 35 years. In both countries, most subjects were newly diagnosed with HIV on the day of enrolment (62%, 55%), believed they already had adequate knowledge to begin ART (78%, 68%), and preferred to start ART immediately (same-day) (98% in both countries). About 40% of all patients had at least one symptom related to tuberculosis (cough, fever, night sweats, weight loss) and/or cryptococcal meningitis (continuous headache). More than a third of patients (37%, 36%) presented with advanced disease (CD4 <200 cells/mm

conclusionsDespite >2 years of universal eligibility for ART in Kenya and South Africa, in 2017-2018 more than half of HIV-positive patients presenting at public sector clinics were not yet aware of their status, and more than a third presented for care with advanced HIV disease. These proportions remain similar to those observed before the introduction of universal eligibility.

Indexed as

AdultAlgorithmsAmbulatory CareAnti-HIV AgentsEligibility DeterminationFemaleHIV InfectionsHumansKenyaMalePoint-of-Care TestingPublic SectorSouth AfricaAnti-HIV AgentsHIV/AIDSpatient characteristicspresenting for carerandomized trialSLATE II South AfricaSLATE I Kenya

Identifiers

PMID31518058
PMCPMC6743421
OpenAlexW2972547467

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.